Kaufman v. Allemang

70 F. Supp. 3d 682, 2014 U.S. Dist. LEXIS 137824, 2014 WL 4954333
CourtDistrict Court, D. Delaware
DecidedSeptember 30, 2014
DocketCiv. No. 13-359-SLR
StatusPublished
Cited by5 cases

This text of 70 F. Supp. 3d 682 (Kaufman v. Allemang) is published on Counsel Stack Legal Research, covering District Court, D. Delaware primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Kaufman v. Allemang, 70 F. Supp. 3d 682, 2014 U.S. Dist. LEXIS 137824, 2014 WL 4954333 (D. Del. 2014).

Opinion

MEMORANDUM OPINION

SUE L. ROBINSON, District Judge

I. INTRODUCTION

Ón March 5, 2013, shareholder plaintiff Jeffery Kaufman (“plaintiff’) filed suit against nominal defendant The Dow Chemical Company (“Dow”), the eleven members of its board of directors, and Dow’s five named executive officers (collectively, “defendants”), asserting direct and derivative claims related to. a series of allegedly false and misleading proxy statements issued annually between 2007 and 2012. (D.I. 1) On May 14, 2013, defendants moved to dismiss the complaint. (D.I. 5) Plaintiff amended his complaint on July 19, 2013, alleging only derivative claims relating to the proxy statements issued between 2007 and 2012. (D.I. 9) Specifically, plaintiff alleges breaches of the duty of disclosure and fiduciary duty, waste of corporate assets, and unjust enrichment. (Id.) Currently before the court is defendants’ motion to dismiss pursuant to Federal Rules of Civil Procedure 23.1 and 12(b)(6). (D.I. 11) The court has jurisdiction pursuant to 28 U.S.C. §§ 1331, 1332, 1340, and 1367.

II. BACKGROUND

A. The Parties

Plaintiff, a citizen of New Jersey, has been a stockholder of Dow continuously since 2006. (D.I. 9 at ¶¶ 1, 5) Dow is a publicly held corporation, incorporated in Delaware, with its principal place of business in Michigan. Dow manufactures and sells products, including raw materials to make other products. (Id. at ¶ 4)

The individual defendants described below are all citizens of states other than New Jersey. (Id. at ¶ 1) As of the date of the original complaint filed in this action, the eleven members of the Dow board of directors (“board”) were Arnold A. Allem-ang (“Allemang”), Ajay Banga (“Banga”), Jacqueline K. Barton (“Barton”), James A. Bell (“Bell”), Jeff M. Fettig (“Fettig”), John B. Hess (“Hess”),1 Andrew N. Liveris (“Liveris”), Paul Polman (“Polman”), Dennis H. Reilley (“Reilley”), James M. Rin-gler (“Ringler”), and Ruth G.. Shaw (“Shaw”). For the 2007 through 2012 stockholders’ annual meetings, the board soliciting proxies consisted of at least Al-lemang, Barton, Bell, Fettig, Hess, Liveris, Geoffery Merszei (“Merszei”), Ringler, and Shaw. (Id. at ¶¶ 6-8, 39)

Since 2009, Barton, Hess, Polman, Reil-ley, and Shaw were the five members of the compensation and leadership development committee (the “committee”). In [687]*6872011, Liveris, William Weideman (“Weide-man”), Joe Harlan (“Harlan”), Charles Kalil (“Kalil”), and Merszei were Dow’s “Named Executive Officers” (“NEOs”). The members of the committee in 2007 and 2008 were Barton, Hess, Ringler, and Shaw. (Id.)

B. The 1988 Plan

On May 12, 1988, the Dow 1988 Award and Option Plan (the “1988 plan”) became effective upon approval of the Dow stockholders. The 1988 plan provided for stock-based compensation, including options, stock appreciation rights, restricted stock, and deferred stock, to employees but not to non-employee directors. The 1988 plan was amended on August 10,1993 by the board to conform with new provisions of the Internal' Revenue Code § 162(m); the stockholders approved such amendments at their annual meeting on May 15, 1997.2 (D.I. 9 at ¶¶ 9-10, 17) The 1997 amendments to the 1988 plan

set forth a number of categories from which performance goals could be set, as follows: (i) earnings, (ii) earnings per share, (iii) share price, (iv) revenues, (v) total shareholder return, (vi) return on invested capital, equity, or assets, (vii) operating margins, (viii) sales growth, (ix) productivity improvement, (x) market share, and (xi) economic profit. The amendments also included annual limits on individual equity-based compensation.

(Id. at ¶ 17) While the 1997 proxy statement reported that I.R.C. § 162(m) required disclosure of these performance goals to the stockholders and the stockholders’ approval thereof, plaintiff alleges that Treasury Regulation § 1.162-27(e)(4)(vi) requires stockholder reappro-val of the performance goals every five years. (Id. at ¶ 18) The board did not seek or obtain such reapproval after the five-year period elapsed in 2002; however, the committee continued to make annual grants under the 1988 plan, even though the 1988 plan stopped being deductible under § 162(m) after 2002.

Plaintiff alleges that the board was fully aware of the tax consequences of its executive compensation based on statements made in Dow’s proxy statements between 1997 and 2001.3 (Id. at ¶¶ 19-25) In 2002, the board sought and obtained stockholder approval of an amendment to the 1988 plan that changed the definition of “employee,” but did not seek reapproval of the plan itself or its performance goals. (Id. at ¶ 26)

Plaintiff alleges that each of the proxy statements from 2002-2006 contained false representations regarding the tax deducti-bility of the executive compensation. For example, the 2003 proxy statement represented that Dow’s “executive performance award and long-term incentive programs are stockholder-approved and are designed to comply with the requirements of Section 162(m).” The 2004 proxy statement represented that the 1988 plan was “approved [688]*688by Dow stockholders in 1988, 1997, and 2002.” {Id. at ¶¶ 26-34)

In accordance with 17 C.F.R. § 229.402(b)(2)(xii), the 2007 proxy statement disclosed “[t]he impact of the ... tax treatment of the particular form of compensation.” {Id. at ¶ 35) The 2007 proxy statement represented:

Section 162(m) of the Internal Revenue Code generally limits the tax deductibility of compensation paid by a public company to its CEO and certain other highly compensated executive officers to $1 million in the year the compensation becomes taxable to the executive. There is an exception to the limit on deductibility for performance-based compensation that meets certain requirements. The Company considers the impact of this rule when developing and implementing the performance award, stock option and performance share programs (described above) which are designed to meet the deductibility requirements. Stockholders have approved the material terms of awards to the covered executives under these programs.

{Id. at ¶ 35) Plaintiff claims that the last sentence of this statement was false or misleading because the performance goals under the 1988 plan had not been reap-proved since 1997. {Id.) As the directors considered the tax consequences of § 162(m) and knew that the 1988 plan had not been reapproved in ten years, plaintiff alleges that making such statements in the 2007 proxy statement was a breach of'the duties of loyalty and care, including the directors’ disclosure duties. {Id.)

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Hurwitz v. LRR Energy, L.P.
241 F. Supp. 3d 491 (D. Delaware, 2017)
Jeffrey Kaufman v. Barbara T. Alexander
625 F. App'x 129 (Third Circuit, 2015)

Cite This Page — Counsel Stack

Bluebook (online)
70 F. Supp. 3d 682, 2014 U.S. Dist. LEXIS 137824, 2014 WL 4954333, Counsel Stack Legal Research, https://law.counselstack.com/opinion/kaufman-v-allemang-ded-2014.